Biochem/physiol Actions
DDRI-18 (DNA Damage Response Inhibitor-18) inhibits nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, and enhances the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin.
- UPC:
- 41106102
- Condition:
- New
- HazmatClass:
- No
- MPN:
- SML0710-5MG
- CAS:
- 4402-18-0
akash.verma@cenmed.com
(732) 447-1115





